Dr Hui-Ming Lin
- 2023Prostate cancer and prostatic diseases10.1038/s41391-023-00666-2
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer.
Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin.
- 2022BMC medicine10.1186/s12916-022-02298-0
Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer.
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase.
Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate Cancer.